vytorin

ZDNet Resources

• sort by:
• Relevance
• Date
• Popularity

Sermo reality check says docs still like Vytorin

Sermo reality check says docs still like VytorinDoes Sermo information accurately reflect physician views?There are at least two independent physicians who would cast doubt on Palestrant's claims:http://HeartMDPhD.com/SermoExposed http://drmeehan.googlepages.com/home

Tags: physician, Sermo, Vytorin, reality check

Discussion threads 2008-05-03

Baby aspirin and the Vytorin scandal

Baby aspirin and the Vytorin scandalBan Drug TV Commercials?I think it has reached the point where Drug commercials dominate the TV air waves and provide a public disservice many mixed signals.That isn't meant as a blanket indictment of Pharmaceutical companies in general, but it would interesting if you put it...

Tags: TVs, Now IT, TV industry, Vytorin, Vytorin scandal, TV

Discussion threads 2008-01-18

Baby aspirin and the Vytorin scandal

You can't learn everything about a compound while it's patented. (Bayer Leverkusen is the only soccer team I know with a pill in its team shield.) Take aspirin. When I was a little kid my mom gave me baby aspirin for headaches. Little, orange, chewable. Delicious. On...

Tags: Patent, Media, U.S. Congress, Vytorin, Heart Attack, Mini-industry, Team Management, Benefits, Management, Human Resources, Dana Blankenhorn

Blog posts 2008-01-18

Additional Resources

Drug profit incompatible with scientific method?

Drug profit incompatible with scientific method?Patentability and ProfitThe problem with new drugs like Vytorin is that we must rely on short-term studies & short-term observation in order to gamble on the drugs' safety. There is, presently, only one cholesterol medication that has not only proven to be most effective in...

Tags: tobacco, new drug, drug company

Discussion threads 2008-09-03

Drug profit incompatible with scientific method?

The NEJM editorial suggests a link may exist between Zetia or Vytorin and cancer, that Schering-Plough and Merck spun studies disputing the link for their own profit. by Dana Blankenhorn

Tags: FDA, Link, Merck & Co. Inc., Schering-Plough Corp., Drug, Consumer Marketing, Drugs, Federal Government, Government, Dana Blankenhorn

Blog posts 2008-09-03

Statin era over?

The era of statins, drugs like Zocor and Lipitor which lower cholesterol levels, may be ending. The FDA's decisions over the last week to reject Merck's Cordaptive and Isis' Mipomersen, coupled with a demand that the makers prove the drugs improve heart outcomes, looks like a turning...

Tags: Gram, Blood Pressure, Merck & Co. Inc., Lipitor, Healthcare, Federal Government, Government, Dana Blankenhorn

Blog posts 2008-05-07

Go with the generic

It was fun this morning, watching the contortions of the morning anchors as they tried to spin the bad news about Zetia without admitting the plain, simple truth. If your cholesterol is high go with the generic. While Zetia and Vytorin, which combines Zetia...

Tags: Generic, Zetia, Insurance, Branding, Operational Accounting, Business Operations, Corporate Insurance, Marketing, Finance, Dana Blankenhorn

Blog posts 2008-03-31

The value in a failed study

I was always told, in science class, that there is no such thing as a failed experiment. There are experiments which don't yield the results you expected, or predicted, or wanted. But these may be more valuable than something that goes according to plan....

Tags: Study, Dana Blankenhorn

Blog posts 2008-01-22

What the electronic medical record movement needs

The march toward automating health records goes on. (Image of stick memory from MedicAlert.) New York has set a goal of getting its basic records online by the end of this year. That's patient charts, referrals, and prescription data. Medical groups are already touting...

Tags: Patient, Electronic Health Record, Health Care, Standards, Quality, E-health, Leadership, Healthcare, Business Operations, Management, Dana Blankenhorn

Blog posts 2008-01-15